Page last updated: 2024-09-03

epilactose and Obesity

epilactose has been researched along with Obesity in 1 studies

*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsui, H; Mori, H; Murakami, Y; Ojima-Kato, T; Saburi, W; Suzuki, T; Tanabe, S1

Other Studies

1 other study(ies) available for epilactose and Obesity

ArticleYear
Supplemental epilactose prevents metabolic disorders through uncoupling protein-1 induction in the skeletal muscle of mice fed high-fat diets.
    The British journal of nutrition, 2015, Dec-14, Volume: 114, Issue:11

    Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Disaccharides; Energy Metabolism; Fermentation; Gastrointestinal Microbiome; Ion Channels; Macrophage Activation; Male; Mice, Inbred C57BL; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Prebiotics; Propionates; Random Allocation; Uncoupling Protein 1; Up-Regulation

2015